4SC AG – Product Pipeline Review – 2012

May 31, 2012 - PRLog -- ReportReserve announces the inclusion of a new report in “Pharmaceuticals and Healthcare” industry.


Summary

Global Market Direct’s pharmaceuticals report, “4SC AG - Product Pipeline Review - 2012” provides data on the 4SC AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, 4SC AG’s corporate website, SEC filings, investor presentations and featured press releases, both from 4SC AG and industry-specific third party sources, put together by Global Markets Direct’s team.



Scope

- 4SC AG - Brief 4SC AG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of 4SC AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of 4SC AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the 4SC AG’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.



Reasons to buy


- Evaluate 4SC AG’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of 4SC AG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the 4SC AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with 4SC AG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of 4SC AG and identify potential opportunities in those areas.


http://www.reportreserve.com/4SC-AG-–-Product-Pipeline-...